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This daily COVID-19 Health Evidence Summary is to signpost DFID and other UK government 
departments to the latest relevant evidence and discourse on COVID-19 to inform and support 
their response. It is a result of 3 hours of work and is not intended to be a comprehensive summary 
of available evidence on COVID-19 but aims to make original documents easily accessible to 
decision makers which, if relevant to them, they should go to before making decisions.   
 
Clinical characteristics and management 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
30.06.2020 Management 
of Mothers 
and Neonates 
in Low 
Resources 
Setting During 
covid-19 
Pandemia 
The Journal of 
Maternal-Fetal 
& Neonatal 
Medicine 
 This perspective aims to 
provide practical support 
for the planning of 
delivery, resuscitating, 
stabilizing, and providing 
postnatal care to an infant 
born to a mother with 
suspected or confirmed 
COVID-19 in low-
resource settings where 
resources for managing 
emergency situations are 
limited. 
Mothers, 
neonates 
Epidemiology and modelling  
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
July 2020 Analyzing 
COVID-19 
pandemic for 
unequal 
Diabetes & 
Metabolic 
Syndrome: 
Clinical 
 This review, identifies 
cases and deaths in 18 
most affected countries by 
COVID-19 cases and 
analyses possible factors 
Age, 
testing 
2 
distribution of 
tests, 
identified 
cases, 
deaths, and 
fatality rates 
in the top 18 
countries 
Research & 
Reviews 
for the differing fatality 
rates. 
 Countries with significant 
percentage of older 
population are vulnerable 
to a high number of deaths 
due to COVID-19. 
Developed countries have 
higher per capita testing, 
whereas testing is less 
intensive in 
developing/underdeveloped 
countries. There is a 
consensus among health 
experts that COVID-19 has 
higher fatality rates for 
people above 60, however, 
with further age, this 
increases exponentially. 
Countries with higher life 
expectancy are also high-
income countries, and the 
best course of action would 
be to provide specialized 
support to self-isolate for 
people of ages 75 and 
above. 
  
Infection Prevention and Control 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
  
30.06.2020 Stability of 
SARS-CoV-2 
and Other 
Coronaviruses 
in the 
Environment 
and on 
Common 
Touch 
Surfaces and 
the Influence 
of Climatic 
Conditions: A 
Review 
Transboundary 
and emerging 
diseases 
 The findings suggest a 
possible risk of fecal-oral, 
foodborne, and 
waterborne transmission 
of SARS-CoV-2 in 
developing countries that 
often use sewage-
polluted waters in 
irrigation and have poor 
water treatment systems. 
CoVs survive longer in 
the environment at lower 
temperatures and lower 
relative humidity. It has 
been suggested that large 
numbers of COVID-19 
cases are associated with 
cold and dry climates in 
Surfaces, 
climate 
  
3 
temperate regions of the 
world and that seasonality 
of the virus spread is 
suspected. 
Indirect impact of COVID-19 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
19.06.2020 Increase in 
the Risk of 
Type 2 
Diabetes 
During 
Lockdown for 
the COVID19 
Pandemic in 
India: A 
Cohort 
Analysis 
Diabetes and 
metabolic 
syndrome 
 Lockdown due to the 
Coronavirus disease 2019 
(COVID 19) pandemic may 
cause weight gain and 
enhance the risk of type 2 
diabetes mellitus (T2DM). 
We aimed to determine this 
risk in apparently non-
diabetic individuals. 
 There was a trend towards 
weight gain seen in 40% of 
the cohort, with 16% of the 
population experiencing a 
2.1-5 kg weight increment. 
When all the risk 
parameters were analyzed 
together using the ADA risk 
engine, there was an 
increase in the ADA 
diabetes risk score in 7% of 
the population, with 6.66% 
in the high-risk group. 
There was a further 
increase in weight among 
3% of the population who 
were already obese at 
baseline. 
Diabetes 
29.06.2020 Impact of 
COVID-19 
Pandemic on 
Paediatric 
Services at a 
Referral 
Centre in 
Pakistan: 
Lessons 
From a Low-
Income and 
Middle-
Income 
Archives of 
Disease in 
Childhood 
 Recommendations: 
paediatric healthcare 
providers must ensure that 
a safe clinic and hospital 
environment is created for 
children with both COVID-
19 and non-COVID-19 
related illnesses so that 
essential preventive care 
and health maintenance 
can be provided to children 
during this time.  
 It is essential to continue to 
spread public health 
awareness messages about 
how to prevent COVID-19 
Children, 
Pakistan 
4 
Country 
Setting 
infection and about the 
importance of routine 
immunisations and seeking 
appropriate advice from 
healthcare providers when 
necessary.  
 If parents are reassured 
that healthcare providers 
will follow standard 
operating procedures and 
will wear and provide 
appropriate PPEs, they may 
be more likely to seek 
appropriate and timely care 
for their children. 
Comments, Editorials, Opinions, Blogs, News 
Publication 
date 
Title/URL Journal | 
Article type 
Author(s) 
29.06.2020 Covid-19: Oxford Team Begins Vaccine 
Trials in Brazil and South Africa to Determine 
Efficacy 
BMJ | News Elisabeth 
Mahase 
30.06.2020 The line is forming for a COVID-19 vaccine. 
Who should be at the front?  
Science | 
News 
Jon Cohen 
Dashboards & Trackers 
Cases & 
deaths: 
Global 
Cases & 
deaths: 
Regional 
Cases & 
deaths: 
Country 
Living 
evidence & 
policy maps 
Current 
research 
including trials 
  Diagnostics  Treatments   Vaccines 
WHO sitreps WHO 
Africa 
Ghana COVID-
NMA 
WHO   FIND 
SARS-CoV-
2 Test 
Tracker 
  Global 
COVID-19 
Clinical Trial 
Tracker 
  CEPI 
WHO 
dashboard 
African 
Arguments 
Indonesia EPPI 
Centre 
WHO 
International 
Clinical Trials 
Registry 
 FIND 
SARS-CoV-
2 
Diagnostics: 
  US NIH 
registered 
clinical trials 
Vaccine 
Centre 
LSHTM 
5 
Platform 
(ICTRP) 
performance 
data 
Johns 
Hopkins 
University 
European 
CDC 
Nigeria 
CDC 
Norwegian 
Institute of 
Public 
Health 
Cytel  Serology-
based tests 
for COVID-
19 
  Solidarity 
trial 
 COVID-
19 Oxford 
Vaccine 
Trial 
WEF 
  Sierra 
Leone 
 Oxford C19 
Government 
Response 
Tracker 
(OxCGRT) 
US NIH  Our World 
in Data: C19 
Testing 
  COVID-19 
Therapeutics 
Accelerator 
  
Our World in 
Data 
  Singapore  Our World 
in Data: 
C19 Policy 
responses 
COVID-
evidence 
      
Global 5050 
  UK  IFPRI 
COVID-19 
Policy 
Response 
Portal 
Cochrane       
CEBM, 
University of 
Oxford 
  US  COVID-19 
Primer 
Clinicaltrials.gov       
Humanitarian 
Data 
Exchange 
     NIH 
LitCovid 
 UKCDR       
Information 
is Beautiful 
     WHO 
COVID-19 
Database 
        
LSHTM               
HealthMap 
(cases) 
              
6 
The 
Commons 
Project 
              
C19 Resource Hubs 
Global  Regional & 
Country 
Academic 
journals & 
Publishers 
Institutes/Centres
/Funders/Other 
Health 
Topics 
  Social 
Sciences 
WHO COVID-
19 pandemic  
Africa CDC Annals of 
Internal 
Medicine 
LSTM Stop TB 
Partnership 
  SSHAP 
WHO risk 
communication 
African 
Union 
BMJ LSHTM 
 
  IDA 
WHO Q&A Nigeria 
CDC 
Bulletin of 
the WHO 
ICL MRC Centre 
for Global 
Infectious 
Disease Analysis 
Global 
Menstrual 
Collective  
  Disability 
and inclusion 
WHO Global 
research 
GeoPoll: 
SSA 
Cambridge 
University 
Press 
ODI SLH: 
Handwashin
g in low 
resource 
settings 
  Coregroup 
IDDC 
COVID-19 
Solidarity 
Response Fund 
Global 
Health 
Network 
Africa 
Cell Press Johns Hopkins 
University 
RBM 
Partnership 
  Ethics, 
health 
systems & 
COVID-19 
UN African 
Academy of 
Sciences 
Cochrane  Center for Global 
Development 
    Social 
Development 
Direct C19 
blog series 
UN Women Africa 
Evidence 
Network 
Elsevier CMMID 
Repository 
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UNOCHA OCHA 
Southern 
and Eastern 
Africa 
COVID-19 
Digest 
JAMA 
Network 
Norwegian 
Institute of Public 
Health 
    
UNHCR  South 
African 
Government 
The 
Lancet 
Oxford Centre for 
Evidence-based 
Medicine 
    
UNICEF   medRxiv 
and 
bioRxiv 
(Preprints) 
 HEART     
UNESCO   NEJM  UKRI     
UN WFP   Oxford 
University 
Press 
 Evidence Aid     
GOARN   PLoS  NIH     
EPI-WIN   SAGE 
journals 
IFPRI Resources 
and Analyses of 
C19 Impact 
    
World Bank   Science  Prevent 
Epidemics  
    
Our World in 
Data 
  Springer 
Nature 
      
COVID-19 
Narratives by 
David Nabarro 
  SSRN 
(Preprints)  
      
Reliefweb   Wiley       
8 
Humanitarian 
OpenStreetMap 
Team 
          
Global 
Partnership for 
Sustainable 
Development 
Data 
  
 
      
WorldPop           
Flowminder           
COVID-END           
Premise 
COVID-19 
Global Impact 
Study 
    
  
GISAID           
Online learning & events 
Date Title/URL Online 
learning/event 
Duration Lead 
30.06.2020 
1000 BST 
Clinical update: 
dexamethasone and 
hydroxychloroquine for 
treatment of severe 
COVID-19  
Webinar   African Academy of 
Sciences 
26.06.2020 
0900 to 
1030 EDT 
Monitoring and 
mitigating the collateral 
effects of COVID-19 
Online event 1h 30 CGD 
13 July 
3:00 PM – 
2020 UCL-Lancet 
Lecture: Global Health 
Preparedness by Dr 
Online 
Lecture  
2 hour 
lecture, 1 
UCL, The Lancet 
9 
6:00 PM 
BST 
Muhammad Pate, 
Global Director for 
Health, Nutrition and 
Population at the World 
Bank Group 
hour panel 
discussion 
June 2020 OpenWHO, the free, 
open-access learning 
platform for health 
emergencies, now 
offers 10 online 
courses related to 
COVID19. 
Online 
courses 
Varies WHO 
24-
25.06.2020 
Africa’s leadership role 
in COVID-19 vaccine 
development and 
access 
Zoom webinar   African Union & Africa 
CDC 
Available 
now 
Standard precautions: 
Environmental cleaning 
and disinfection 
Online course 1 hour WHO 
Available 
now 
COVID-19: Effective 
Nursing in Times of 
Crisis 
Online course 2 weeks – 2 
hours per 
week 
Johns Hopkins School 
of Nursing 
Available 
now 
WHO Academy and 
WHO Info mobile 
applications 
Mobile app   WHO 
Available 
now 
COVID-19: Pandemics, 
Modelling and Policy 
Online 
learning 
2 weeks | 2 
hours 
weekly 
study 
FutureLearn 
UNESCO UNITWIN 
Complex Systems 
Digital Campus/Open 
University 
12.05.2020 COVID-19 and 
maintaining quality 
essential health 
services  
Webinar 1 hour WHO & ISQua – Dr 
Shams Syed, Dr 
Peter Lachman, Dr 
Teri Rynolds & Dr Ed 
Kelley 
10 
11.5.2020 COVID-19 Contact 
Tracing course 
Online 
learning 
5 hours Johns Hopkins 
Bloomberg School of 
Health 
7-28 May 
2020 
Virtual Evidence Weeks 5 sessions 1h 30 International Initiative 
for Impact Evaluation 
(3ie) 
Tuesdays 
at 1700 
CEST 
(Geneva 
time) & 
Thursdays 
0830 CEST 
(Geneva 
time) 
COVID-19 Open online 
brief with Dr David 
Nabarro 
Event 1h 4SD 
30.04.2020 Professor Chris 
Whitty’s Gresham 
lecture on COVID-19 
Event 1h 20 Gresham College 
Available 
now 
Emerging respiratory 
viruses, including 
COVID-19: methods for 
detection, prevention, 
response and control 
Online 
learning 
3 hours WHO 
Available 
now 
Responding to COVID-
19: Real-time training 
for the coronavirus 
disease outbreak 
Online 
learning 
Multiple 
self-paced 
course 
WHO 
25 May 
2020 
COVID-19: Tackling the 
Novel Coronavirus 
Online 
learning 
3 weeks | 4 
hours 
weekly 
study 
FutureLearn 
LSHTM/UK PHRST 
Available 
online now 
without 
mentors. 
Updated 
version will 
COVID-19 Diagnostics 
and Testing 
Online 
learning 
3 weeks | 3 
hours 
weekly 
study 
FutureLearn 
FIND/LSHTM/ASLM 
11 
commence 
early June 
2020 
6 April 2020 COVID-19 Critical 
Care: Understanding 
and Application 
Online 
learning 
5 weeks | 1 
hour weekly 
study 
FutureLearn 
University of 
Edinburgh & Royal 
College of Physicians 
of Edinburgh  
Available 
now 
COVID-19 supporting 
online courses 
Online 
learning 
Multiple 
self-paced 
course 
BMJ Learning 
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Rapid review methodology 
The rapid daily search for peer-reviewed literature is carried out through a PubMed search with the following 
keywords (“COVID-19” OR “severe acute respiratory syndrome coronavirus 2” OR “2019-nCoV” OR “SARS-CoV-
2” OR “2019nCoV” OR “coronavirus” ) AND (“Africa”) OR (“equity” OR “equities”) OR (“poverty”), restricted to 
articles published in the previous 2 to 3 days, in English. This is complemented by a search of the homepage of 
the following high-impact global health journals: The Lancet journals, New England Journal of Medicine, Nature, 
JAMA, Annals of Internal Medicine, Cochrane Reviews, BMJ Global Health, the PLoS journals and a Twitter 
search of their Twitter pages. A search also of preprints from bioRxiv and medRxiv. Please note that papers that 
have not been peer-reviewed are highlighted in red. All primary research papers that relate to the primary and 
secondary impacts of the COVID-19 response in LMICs, and disease control and health system responses are 
included. Articles related to tackling the secondary impacts on other sectors are not included. Additional 
commentaries, opinions, and commissioned pieces are selected based on relevance. 
The search for dashboards, guidelines, tools, editorials, comments, blogs, opinions and news is through the 
academic journals listed above, C19 resource hubs and following lead academics and professionals on Twitter. 
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About this report 
This daily COVID-19 health evidence summary (HES) is based on 3 hours of desk-based research. The 
summary is not intended to be a comprehensive summary of available evidence on COVID-19 but aims to make 
original documents easily accessible to decision makers which, if relevant to them, they should go to before 
making decisions. The HES are not intended to replace medical or professional advice and the researcher or the 
K4D consortium cannot be held responsible for any decisions made about COVID-19 on the basis of the HES 
alone. K4D services are provided by a consortium of leading organisations working in international development, 
led by the Institute of Development Studies (IDS), with Education Development Trust, Itad, University of Leeds 
Nuffield Centre for International Health and Development, Liverpool School of Tropical Medicine (LSTM), 
University of Birmingham International Development Department (IDD) and the University of Manchester 
Humanitarian and Conflict Response Institute (HCRI). 
This evidence summary was prepared for the UK Government’s Department for 
International Development (DFID) and its partners in support of pro-poor programmes. 
It is licensed for non-commercial purposes only. K4D cannot be held responsible for 
errors, omissions or any consequences arising from the use of information contained in 
this health evidence summary. Any views and opinions expressed do not necessarily 
reflect those of DFID, K4D or any other contributing organisation.  
© DFID - Crown copyright 2020. 
 
